The Federal Government of Nigeria has announced an ambitious plan to produce 70% of the country's pharmaceuticals and a significant portion of its vaccines locally by 2030. This initiative, unveiled by the Coordinating Minister of Health and Social Welfare, Prof. Muhammad Pate, is part of a broader strategy to enhance healthcare self-sufficiency and stimulate economic growth.

Key Components of the Initiative

• Establishment of Empower Academy Nigeria: A specialized training hub aimed at boosting local pharmaceutical and medical device manufacturing. The academy will focus on advanced manufacturing, regulatory sciences, and quality assurance.

• Presidential Initiative to Unlock the Healthcare Value Chain (PVAC): Launched in October 2023, PVAC aims to attract investments and facilitate the establishment of pharmaceutical manufacturing companies. ​

• Investment and Partnerships: The government is securing significant financing, including €1 billion from the European Investment Bank and $1 billion from AFREXIMBANK, to support incoming manufacturers in the health and life sciences sector.

Expected Outcomes

• Workforce Development: Training and upskilling thousands of Nigerians annually in various aspects of pharmaceutical manufacturing.​

• Economic Growth: Doubling Nigeria’s pharmaceutical market share in Africa to at least 15%.​

• Healthcare Improvement: Enhancing access to quality medicines and reducing dependency on imports.​

This strategic move is expected to position Nigeria as a regional hub for pharmaceutical manufacturing, addressing critical workforce gaps and ensuring sustainable development in the healthcare sector.